Pharmacy Group Pans FDA Decision to Approve New Ella Abortion Drug
by Steven Ertelt
August 16, 2010
Washington, DC (LifeNews.com) — A national organization for pro-life pharmacists is panning a decision by the Food and Drug Administration to approve the new Ella drug that is billed as an improved morning after pill but causes abortions. The drug will be available to women by prescription and it destroys unborn children days after conception.
The drug is called a morning after pill by its maker HRA Pharma, distributor Watson Pharmaceuticals, and the FDA because they have redefined the beginning of human life as implantation instead of conception, or fertilization.
But Pharmacists For Life International, in a statement to LifeNews.com, confirms the abortifacient nature of the Ella drug.
PFLI calls Ella a "chemical cousin analog of mifepristone," the abortion drug more commonly known by its experimental name, RU 486. "Ulipristal acetate, according to its own developers, can kill embryos," it confirms.
The organization said it "vehemently denounces and condemns the FDA for this inappropriate use of its drug regulatory power to destroy life rather than approve and regulate medicines which actually are life-saving and preserve health."
PFLI says it is concerned women will purchase the drug and stockpile it in large doses and sidestep the routine surgical or durg-induced abortion process with dangerous at-home abortions. It also worries the drug will be used by men who want to hide evidence of their crimes of sexual assault.
"This will lead to additional life-endangering problems for the targeted adolescent girls and women, as well as giving continued cover for sexual predators of underage girls and incestuous abusive relationships," the group worries.
PFLI says the FDA should be focused less on approving another abortion drug and more on the shortages of legitimate medicines pharmacists are seeing nationwide.
"In many places of employment a gigantic board is posted listing the shortages and outages of essential medications, such as antibiotics, pain relievers, [and] anesthetics," PFLI says. "This problem has been significant for years, and has worsened considerably in the last year, impeding pharmacists’ ability to provide vital care for our patients."
The FDA "would have served the citizens of the US better by adequately addressing the current, rolling shortages of truly lifesaving and essential medications, rather than chemicals whose main intent is to snuff out a nascent life in the first few weeks of existence," it added.
The national pharmacists group called the decision an "inappropriate use of its drug regulatory power to destroy life rather than approve and regulate medicines which actually are life-saving and preserve health."
Meanwhile, David Bereit, the head of the national 40 Days for Life effort, also condemned the FDA decision. Before his involvement in grassroots pro-life efforts, Bereit worked in pharmaceutical sales and marketing.
"One of the drugs I sold was Cytotec — chemically known as misoprostol," he told LifeNews.com last Friday in a conference call. "The drug was not intended for abortion — far from it. It is a synthetic prostaglandin designed and indicated for the treatment of gastric ulceration, particularly those caused by the side effects of common Non-steroidal anti-inflammatory drugs."
"However, Cytotec was fully tested, and was found to have abortifacient properties," he explained. "Because of this risk, the FDA required that Cytotec carry a black box warning label informing consumers of the risk to pregnant women, revealing that the drug could cause an early abortion and stating that it should not be used by women who are, or may, become pregnant."
"In that case, the FDA did not choose politics over principle. They required proper testing, and they put the health and safety of women and children first," Bereit said.
However, the decision to approve the Ella abortion drug for sale in the United States has the FDA "choosing political ideology and the abortion industry’s radical agenda over women’s health and the safety of their children," Bereit said.
Bereit confirmed Ella is an abortion drug and not merely a morning after pill.
"You don’t need to be a clinical pharmacologist or medical doctor to figure that out," he said. "It comes from the same chemical family as the RU-486 abortion drug, and works through virtually the same mechanism of action — one that can abort a human life at the earliest stages by blocking implantation on the uterine wall, causing that new life to be killed."
He said HRA Pharma, knowing that the majority of Americans oppose abortion, decided to avoid the controversy associated with the abortion drug label and engaged in a bait and switch, "marketing the drug only as a contraceptive, for use up to 120 hours after sex — even though they know the chemical’s mechanism of action full well."
"This company, motivated by the potential of windfall profits, has tried to use smoke and mirrors and distract the issue by saying that there is no evidence of ella causing abortions — well, there’s a perfectly good explanation for that," Bereit says. "HRA Pharma failed to do the tests that could show that ella indeed does cause abortions."
Bereit suggests that’s because the ella abortion drug maker knew the tests would reveal it causes abortions.
"And, unfortunately today, the FDA is buckling to administration pressure and the whims of the abortion lobby," Bereit concludes. "By approving Ella, without full testing that would reveal its harmful effects, they are choosing to look the other way and abandon women and children."
Related web sites:
Pharmacists for Life International – https://www.pfli.org
Sign Up for Free Pro-Life News From LifeNews.com
Daily Pro-Life News Report Twice-Weekly Pro-Life
News Report Receive a free daily email report from LifeNews.com with the latest pro-life news stories on abortion, euthanasia and stem cell research. Sign up here. Receive a free twice-weekly email report with the latest pro-life news headlines on abortion, euthanasia and stem cell research. Sign up here.